Target intelligence / Profile preview

Cell-surface complex N-glycan-bearing receptors and adhesion molecules

Molecular classification
Receptor, Adhesion molecule, Glycoprotein
01

Overview

Cell-surface complex N-glycan-bearing receptors and adhesion molecules represent a functional class of glycoproteins, including EGFR, TGF-beta receptors, and integrins, that are modified with beta-1,6-branched N-glycans by the enzyme MGAT5 (Dennis et al., 2009, Cell). These glycans act as ligands for galectins, particularly Galectin-3, which cross-links them to form a dynamic "galectin-glycan lattice" on the cell surface (Lau et al., 2007, Cell). This lattice is a critical regulator of cell signaling, as it prevents the constitutive endocytosis of the receptors, thereby maintaining their presence and activity at the plasma membrane. In diseases such as cancer and fibrosis, the lattice is often reinforced, leading to aberrant signaling that promotes tumor progression, metastasis, and tissue scarring (Partridge et al., 2004, Science). Therapeutic intervention typically involves small molecules or carbohydrate-based inhibitors that target the galectin's carbohydrate-recognition domain, thereby disrupting the lattice and allowing for the internalization and degradation of the associated receptors (Blanchard et al., 2014, Chem Biol).

Other names
Complex N-glycan-containing glycoproteinsGalectin ligandsMGAT5-modified receptorsN-linked glycoprotein receptorsBeta-1,6-branched N-glycan-bearing receptors
02

Mechanism of action

Inhibition of galectin binding to the carbohydrate-recognition domain of complex N-glycan-bearing receptors, which disrupts the galectin-glycan lattice and promotes receptor internalization and degradation.

03

Biological functions

Signal transductionCell adhesionEndocytosis regulationProtein traffickingLattice formationPlasma membrane organization
04

Disease associations

CancerInflammationFibrosisMetastasisLiver cirrhosis
05

Safety considerations

Off-target effects on normal cell adhesionPotential for systemic glycan-binding interferenceModulation of immune cell homeostasis and T-cell apoptosisLimited specificity for diseased versus healthy tissue glycans
06

Interacting drugs

Belapectin (GR-MD-02)

3 more in the full profile.

07

Biomarkers

Galectin-3 expression levelsMGAT5 (GnT-V) expressionL-PHA (Phaseolus vulgaris leucoagglutinin) reactivitySerum Galectin-3

Beyond the preview

Go deeper on Cell-surface complex N-glycan-bearing receptors and adhesion molecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface complex N-glycan-bearing receptors and adhesion molecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call